CDIO

Cardio Diagnostics Holdings Inc. Common stock (CDIO)

Stock · NASDAQ · Health Care

$1.69as of 10/16/2026

Active signals

Resistance level
$1.85
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances

What CDIO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike31-10.2%45%
Bollinger Band Breakdown20-14.7%30%
Bollinger Band Breakout13+6.8%69%
200-Day Moving Average TouchActive now5-20.2%20%
Any 20-session window (baseline)-13.9%31%

Computed by MarketWall from daily closing prices since October 31, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About CDIO

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable C…

Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Employees
15

Fundamentals

1-day range
$1.69$1.84
Market cap
$4.91M
P/E (trailing)
—
P/E (forward)
-6.76
EPS (trailing)
$-2.92
Dividend yield
—
Beta
2.30
Avg. volume
57.0K
52-week range
$0.97$7.91
Next earnings: August 13, 2026confirmed

How Cardio Diagnostics Holdings Inc. Common stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$14.8KSG&A$5.79M (39072%)R&D$641.2K (4325%)CDIO

Source: 10-K filed Mar 13, 2026 · via SEC EDGAR / Finnhub

Operating Income-$6.48M(-43737%)

Cardio Diagnostics Holdings Inc. Common stock Competitors

Chosen by industry and closest market cap.

  • CDIO
    Cardio Diagnostics Holdings Inc. Common stock
    $1.69
    ▼ 3.98%
    Market cap $4.91MP/E —
    $0.97$7.91
  • BMRA
    Biomerica Inc. Common Stock
    $1.85
    ▼ 1.60%
    Market cap $4.94MP/E —
    $1.45$3.21
  • VRAX
    Virax Biolabs Group Limited Ordinary Shares
    $1.45
    ▼ 10.49%
    Market cap $2.21MP/E —
    $1.55$21.75
  • TRIB
    Trinity Biotech plc American Depositary Shares
    $8.03
    ▲ 1.26%
    Market cap $7.86MP/E —
    $5.01$52.5
  • VNRX
    VolitionRX Limited Common Stock
    $0.18
    ▼ 5.26%
    Market cap $9.23MP/E —
    $0.18$10.31
  • CDIOW
    Cardio Diagnostics Holdings Inc. Warrant
    $0.0064
    ▼ 28.09%
    Market cap $50.3KP/E —
    $0.0052$0.0721
  • QCLS
    Q/C Technologies Inc. Common Stock
    $0.538
    ▼ 3.58%
    Market cap $21.99MP/E —
    $0.4201$8.17

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
24.6K
Disposed
0
  • Fung Peter K · September 30, 2026 · Grant
    3.3K @ $1.9
  • Betts Wendy J · September 30, 2026 · Grant
    3.3K @ $1.9
  • Paul Frederick Burton · September 30, 2026 · Grant
    3.3K @ $1.9
  • James Intrater · September 30, 2026 · Grant
    3.3K @ $1.9
  • Paul Frederick Burton · June 30, 2026 · Grant
    2.9K @ $2.19
  • James Intrater · June 30, 2026 · Grant
    2.9K @ $2.19
  • Fung Peter K · June 30, 2026 · Grant
    2.9K @ $2.19
  • Betts Wendy J · June 30, 2026 · Grant
    2.9K @ $2.19

Institutional Ownership

March 31, 2026

Total shares held
272.4K
Total value held
$409.4K
Institutional holders
15
Top holders this quarter
  • Unknown81.3K
  • Unknown62.5K
  • Unknown34.7K
  • Unknown32.2K
  • Unknown20.2K
  • Unknown15.3K
  • Unknown13.9K
  • Unknown9.9K
  • Unknown2.2K
  • Unknown104

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.